A prospective observational study for the impact of pemafibrate on cardio-ankle vascular index (CAVI)
Not Applicable
Recruiting
- Conditions
- hypertriglyceridemia
- Registration Number
- JPRN-UMIN000046474
- Lead Sponsor
- Toho University, Sakura Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are not considered to have sufficient ability to consent or refuse Minor patients
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in CAVI after 6 months treatment
- Secondary Outcome Measures
Name Time Method